Granulocyte-colony stimulating factor ameliorates di-ethylhexyl phthalate-induced cardiac muscle injury via stem cells recruitment, Desmin protein regulation, antifibrotic and antiapoptotic mechanisms.

[1]  Zeng Wen,et al.  Adverse cardiovascular effects and potential molecular mechanisms of DEHP and its metabolites-A review. , 2022, The Science of the total environment.

[2]  Xufeng Wang,et al.  Prenatal di-(2-ethylhexyl) phthalate exposure induced myocardial cytotoxicity via the regulation of the NRG1-dependent ErbB2/ErbB4-PI3K/AKT signaling pathway in fetal mice. , 2022, Ecotoxicology and environmental safety.

[3]  Jianli Cui,et al.  DEHP-induced mitophagy and mitochondrial damage in the heart are associated with dysregulated mitochondrial biogenesis. , 2022, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  Fan Yang,et al.  Di-2-ethylhexyl phthalate induces heart looping disorders during zebrafish development , 2021, Toxicology and industrial health.

[5]  U. Bogdahn,et al.  Granulocyte colony-stimulating factor in traumatic spinal cord injury. , 2021, Drug discovery today.

[6]  Y. M. Abd-Elhakim,et al.  Di(2-ethylhexyl) adipate plasticizer triggers hepatic, brain, and cardiac injury in rats: Mitigating effect of Peganum harmala oil. , 2021, Ecotoxicology and environmental safety.

[7]  E. Cairrão,et al.  Phthalates Implications in the Cardiovascular System , 2020, Journal of cardiovascular development and disease.

[8]  G. Cuda,et al.  Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges , 2020, International journal of molecular sciences.

[9]  B. Prendergast,et al.  Advances in transcatheter mitral and tricuspid therapies , 2020, BMC Cardiovascular Disorders.

[10]  Yingren Li,et al.  A multi-omics approach reveals molecular mechanisms by which phthalates induce cardiac defects in zebrafish (Danio rerio). , 2020, Environmental pollution.

[11]  Naima Hamid,et al.  Effects of phthalate acid esters on zebrafish larvae: Development and skeletal morphogenesis. , 2019, Chemosphere.

[12]  E. Cartwright,et al.  Cardiomyocyte damage control in heart failure and the role of the sarcolemma , 2019, Journal of Muscle Research and Cell Motility.

[13]  S. Abdel-gawad,et al.  Pulmonary toxicity induced by exposure to phthalates, an experimental study , 2019, Inhalation toxicology.

[14]  Wei Shen,et al.  Identification of oxidative stress–related Xdh gene as a di(2‐ethylhexyl)phthalate (DEHP) target and the use of melatonin to alleviate the DEHP‐induced impairments in newborn mouse ovaries , 2019, Journal of pineal research.

[15]  F. Neffati,et al.  Di (2-ethylhexyl) phthalate induces cardiac disorders in BALB/c mice , 2019, Environmental Science and Pollution Research.

[16]  Jin-Long Li,et al.  Modulation of heat-shock response is associated with Di (2-ethylhexyl) phthalate (DEHP)-induced cardiotoxicity in quail (Coturnix japonica). , 2019, Chemosphere.

[17]  O. Erbaş,et al.  Granulocyte Colony-Stimulating Factor Prevents Ischemia/Reperfusion-Induced Ovarian Injury in Rats: Evaluation of Histological and Biochemical Parameters , 2018, Reproductive Sciences.

[18]  M. Mavroidis,et al.  Intermediate filaments in cardiomyopathy , 2018, Biophysical Reviews.

[19]  Changjiang Liu,et al.  Roles and potential mechanisms of selenium in countering thyrotoxicity of DEHP. , 2018, The Science of the total environment.

[20]  Sai Sandeep Singh Rowdhwal,et al.  Toxic Effects of Di-2-ethylhexyl Phthalate: An Overview , 2018, BioMed research international.

[21]  Y. Hua,et al.  The effect of maternal exposure to di‐(2‐ethylhexyl)‐phthalate on fetal cardiac development in mice , 2018, Journal of applied toxicology : JAT.

[22]  David F Wilson,et al.  Granulocyte colony-stimulating factor significantly decreases density of hippocampal caspase 3-positive nuclei, thus ameliorating apoptosis-mediated damage, in a model of ischaemic neonatal brain injury. , 2017, Interactive cardiovascular and thoracic surgery.

[23]  W. Peng.  Neuroprotective effects of G-CSF administration in microglia-mediated reactive T cell activation in vitro , 2017, Immunologic Research.

[24]  J. Lammerding,et al.  Connecting the plasma membrane to the nucleus by intermediate filaments , 2017, Molecular biology of the cell.

[25]  Ping Chen,et al.  Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes , 2015, PloS one.

[26]  Y. Rojanasakul,et al.  Nitrosothiol signaling and protein nitrosation in cell death. , 2014, Nitric oxide : biology and chemistry.

[27]  H. Takano,et al.  Involvement of hemeoxygenase-1 in di(2-ethylhexyl) phthalate (DEHP)-induced apoptosis of Neuro-2a cells. , 2014, The Journal of toxicological sciences.

[28]  Leonard Leibovici,et al.  Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato‐oncological patients: Randomized controlled trial , 2014, American journal of hematology.

[29]  G. Steinbeck,et al.  Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. , 2013, International journal of cardiology.

[30]  S. Engel,et al.  Causal inference considerations for endocrine disruptor research in children's health. , 2013, Annual review of public health.

[31]  L. Ouyang,et al.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis , 2012, Cell proliferation.

[32]  M. Pronicki,et al.  Type of desmin expression in cardiomyocytes – a good marker of heart failure development in idiopathic dilated cardiomyopathy , 2012, Journal of internal medicine.

[33]  P. Mcneil,et al.  Promotion of plasma membrane repair by vitamin E , 2011, Nature communications.

[34]  Y. Lim,et al.  Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats , 2011, Cardiovascular diabetology.

[35]  H. F. Carvalho,et al.  The Antiapoptotic Effect of Granulocyte Colony-stimulating Factor Reduces Infarct Size and Prevents Heart Failure Development in Rats , 2011, Cellular Physiology and Biochemistry.

[36]  Patrick M. McLendon,et al.  Desmin-related cardiomyopathy: an unfolding story. , 2011, American journal of physiology. Heart and circulatory physiology.

[37]  N. Maraldi,et al.  Prelamin A-mediated recruitment of SUN1 to the nuclear envelope directs nuclear positioning in human muscle , 2011, Cell Death and Differentiation.

[38]  Ronald P. Brown,et al.  Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. , 2011, Toxicology.

[39]  R. Ribeiro‐dos‐Santos,et al.  Granulocyte colony‐stimulating factor treatment in chronic Chagas disease: preservation and improvement of cardiac structure and function , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Ronald P. Brown,et al.  Clinically relevant concentrations of di (2-ethylhexyl) phthalate (DEHP) uncouple cardiac syncytium. , 2009, Toxicology and applied pharmacology.

[41]  José A. Ramos-Vara,et al.  Suggested Guidelines for Immunohistochemical Techniques in Veterinary Diagnostic Laboratories , 2008, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[42]  G. Takemura,et al.  Effect of a long-term treatment with a low-dose granulocyte colony-stimulating factor on post-infarction process in the heart , 2008, Journal of cellular and molecular medicine.

[43]  Giselle Chamberlain,et al.  Recent advances into the understanding of mesenchymal stem cell trafficking , 2007, British journal of haematology.

[44]  G. Takemura,et al.  Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy , 2007, Laboratory Investigation.

[45]  M. Naito,et al.  Short-term effects of di-(2-ethylhexyl) phthalate on testes, liver, kidneys and pancreas in mice. , 2007, Asian journal of andrology.

[46]  T. Lømo,et al.  Blood vessels and desmin control the positioning of nuclei in skeletal muscle fibers , 2006, Journal of cellular physiology.

[47]  I. Hoefer,et al.  G-csf Administration after Myocardial Infarction in Mice Attenuates Late Ischemic Cardiomyopathy by Enhanced Arteriogenesis , 2022 .

[48]  S. Ogawa,et al.  Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. , 2005, Cardiovascular research.

[49]  S. Kitamura,et al.  G-CSF Promotes Bone Marrow Cells to Migrate into Infarcted Mice Heart, and Differentiate into Cardiomyocytes , 2004, Cell transplantation.

[50]  Manuela M. Santos,et al.  Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin. , 2003, Blood.

[51]  J. Nagle,et al.  Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations , 2003, Neuromuscular Disorders.

[52]  M. Tokuda,et al.  Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate. , 2002, The Biochemical journal.

[53]  R. M. David,et al.  Reversibility of the Chronic Effects of Di(2-ethylhexyl)phthalate , 2001, Toxicologic pathology.

[54]  J. Schaper,et al.  Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. , 2000, Journal of molecular and cellular cardiology.

[55]  R. M. David,et al.  Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  E. Osuna,et al.  Biochemical assessment of acute myocardial ischaemia. , 1995, Journal of clinical pathology.

[57]  J. Henao-Mejia,et al.  Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health , 2018, Endocrinology.

[58]  G. Takemura,et al.  Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure , 2006, Laboratory Investigation.